Russell P. Goodman

Gastroenterology

55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Development and psychometric evaluation of the Liver Disease Stigma Scale (LDSS).

Development and psychometric evaluation of the Liver Disease Stigma Scale (LDSS).

Journal: JHEP reports : innovation in hepatology

Published: February 21, 2026

LiRNA: An interactive atlas of human liver RNAseq databases.

LiRNA: An interactive atlas of human liver RNAseq databases.

Journal: JHEP reports : innovation in hepatology

Published: January 30, 2026

LiRNA: An Interactive Atlas of Human Liver RNAseq Databases.

LiRNA: An Interactive Atlas of Human Liver RNAseq Databases.

Journal: JHEP reports : innovation in hepatology

Published: January 30, 2026

Glucagon-like peptide-1 receptor agonist reduces risk of alcohol-associated cirrhosis in type 2 diabetes and alcohol use disorder patients.

Glucagon-like peptide-1 receptor agonist reduces risk of alcohol-associated cirrhosis in type 2 diabetes and alcohol use disorder patients.

Journal: European journal of gastroenterology & hepatology

Published: November 17, 2025

Phosphatidylethanol testing: patterns, demographic and clinical correlates, and outcomes.

Phosphatidylethanol testing: patterns, demographic and clinical correlates, and outcomes.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire)

Published: June 06, 2025

A genetically encoded bifunctional enzyme mitigates redox imbalance and lipotoxicity.

A genetically encoded bifunctional enzyme mitigates redox imbalance and lipotoxicity.

Journal: Nature metabolism

Published: March 20, 2025

Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.

Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.

Journal: Hepatology communications

Published: March 16, 2025

Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency.

Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency.

Journal: Nature metabolism

Published: January 23, 2025

Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.

Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.

Journal: The American journal of gastroenterology

Published: January 14, 2025

Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in Citrin Deficiency.

Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in Citrin Deficiency.

Journal: bioRxiv : the preprint server for biology

Published: January 07, 2025

Loss of Mtarc1 Protects Against Steatotic Liver Disease in Mice.

Loss of Mtarc1 Protects Against Steatotic Liver Disease in Mice.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 29, 2024

Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD).

Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD).

Journal: Journal of clinical and experimental hepatology

Published: September 10, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026